221. Anti-glomerular basement membrane disease Clinical trials / Disease details


Clinical trial : 1 Drugs : 3 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03157037
(ClinicalTrials.gov)
March 1, 201711/5/2017An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES)An Open-Label Phase II Study in Anti-GBM Disease (Goodpasture's Disease) With Adverse Renal Prognosis to Evaluate the Efficacy and Safety of IdeS --GOOD-IDESAnti-Glomerular Basement Membrane DiseaseBiological: HMed-IdeSMårten SegelmarkHansa Biopharma ABCompleted18 YearsN/AAll15Phase 2Austria;Czechia;Denmark;France;Sweden